These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34299526)

  • 1. Direct Assessment of Oligomerization of Chemically Modified Peptides and Proteins in Formulations using DLS and DOSY-NMR.
    Wang K; Chen K
    Pharm Res; 2023 Jun; 40(6):1329-1339. PubMed ID: 36627448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of NMR and Chemometric Analyses to Better Understand the Quality Attributes in pH and Thermally Degraded Monoclonal Antibodies.
    Beaumont VA; Liu L; Shi H; Rouse JC; Kim HY
    Pharm Res; 2023 Oct; 40(10):2457-2467. PubMed ID: 37798537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multivariate Analysis of Two-Dimensional
    Arbogast LW; Delaglio F; Schiel JE; Marino JP
    Anal Chem; 2017 Nov; 89(21):11839-11845. PubMed ID: 28937210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Best Practices for Submission of NMR Data to Support Higher Order Structure Assessment of Generic Peptide Drugs.
    Chen K; Smith CJ
    AAPS J; 2023 Jan; 25(1):17. PubMed ID: 36670271
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemometric Outlier Classification of 2D-NMR Spectra to Enable Higher Order Structure Characterization of Protein Therapeutics.
    Sheen DA; Shen VK; Brinson RG; Arbogast LW; Marino JP; Delaglio F
    Chemometr Intell Lab Syst; 2020; 199():. PubMed ID: 34135539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Generic Teriparatide: Structural and Biological Sameness to Its Reference Medicinal Product.
    Fernández-Carneado J; Vallès-Miret M; Arrastia-Casado S; Almazán-Moga A; Macias MJ; Martin-Malpartida P; Vilaseca M; Díaz-Lobo M; Vazquez M; Sanahuja RM; Gambús G; Ponsati B
    Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR reveals an undeclared constituent in custom synthetic peptides.
    Choules MP; Bisson J; Simmler C; McAlpine JB; Giancaspro G; Bzhelyansky A; Niemitz M; Pauli GF
    J Pharm Biomed Anal; 2020 Jan; 178():112915. PubMed ID: 31671336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical sameness methodology for the evaluation of structural, physicochemical, and biological characteristics of Armlupeg: A pegfilgrastim biosimilar case study.
    Deshmukh A; Goyal R; Sundaram K; Dange K; Lakhote T; Niranjan S; Bharucha J; Mishra A; Vats B; Tiwari S
    PLoS One; 2023; 18(8):e0289745. PubMed ID: 37556495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of NMR Spectroscopy in an Analytical Workflow to Evaluate the Effects of Oxidative Stress on Abituzumab: Beyond the Fingerprint of mAbs.
    Cerofolini L; Ravera E; Fischer C; Trovato A; Sacco F; Palinsky W; Angiuoni G; Fragai M; Baroni F
    Anal Chem; 2023 Jun; 95(24):9199-9206. PubMed ID: 37278511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Precise qNMR Method for the Rapid Quantification of Lot-to-Lot Variations in Multiple Quality Attributes of Pentosan Polysulfate Sodium.
    Wang K; Dai W; Qian K; Scott B; Chen K
    AAPS J; 2023 May; 25(3):50. PubMed ID: 37147461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical Applications of NMR to Solve Real-World Problems.
    Brinson RG
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.
    Chen K; Park J; Li F; Patil SM; Keire DA
    AAPS PharmSciTech; 2018 Apr; 19(3):1011-1019. PubMed ID: 29110294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy.
    Amezcua CA; Szabo CM
    J Pharm Sci; 2013 Jun; 102(6):1724-1733. PubMed ID: 23568791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR spectroscopy as a characterization tool enabling biologics formulation development.
    Ma J; Pathirana C; Liu DQ; Miller SA
    J Pharm Biomed Anal; 2023 Jan; 223():115110. PubMed ID: 36308923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR Spectroscopy for Protein Higher Order Structure Similarity Assessment in Formulated Drug Products.
    Wang D; Zhuo Y; Karfunkle M; Patil SM; Smith CJ; Keire DA; Chen K
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NMR-Based Similarity Metric for Higher Order Structure Quality Assessment Among U.S. Marketed Insulin Therapeutics.
    Wang D; Park J; Patil SM; Smith CJ; Leazer JL; Keire DA; Chen K
    J Pharm Sci; 2020 Apr; 109(4):1519-1528. PubMed ID: 31927041
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.